Cargando…

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Krashia, Paraskevi, Nobili, Annalisa, D'Amelio, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534044/ https://www.ncbi.nlm.nih.gov/pubmed/31156387 http://dx.doi.org/10.3389/fnmol.2019.00123

Ejemplares similares

The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
por: Krashia, Paraskevi, et al.
Publicado: (2022)

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
por: Nobili, Annalisa, et al.
Publicado: (2017)

Upregulation of Ca(2+)-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer’s disease in Tg2576 mice
por: La Barbera, Livia, et al.
Publicado: (2022)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism
por: Pignataro, Annabella, et al.
Publicado: (2023)

A Unifying Hypothesis for Familial and Sporadic Alzheimer's Disease
por: Proctor, Carole J., et al.
Publicado: (2012)

Ventral tegmental area disruption in Alzheimer’s disease
por: Bozzali, Marco, et al.
Publicado: (2019)

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
por: D’Amelio, Marcello, et al.
Publicado: (2023)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases
por: Golde, Todd E, et al.
Publicado: (2009)

Lysosomal Fusion Dysfunction as a Unifying Hypothesis for Alzheimer's Disease Pathology
por: Funk, Kristen E., et al.
Publicado: (2012)

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
por: Corsetti, Veronica, et al.
Publicado: (2020)

Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer’s Disease
por: Kaeser, Gwendolyn E., et al.
Publicado: (2020)

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
por: La Barbera, Livia, et al.
Publicado: (2022)

Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
por: Caligiore, Daniele, et al.
Publicado: (2020)

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
por: Jagaran, Keelan, et al.
Publicado: (2021)

Hippocampal epileptogenesis in autoimmune encephalitis
por: Romoli, Michele, et al.
Publicado: (2019)

The Quest for Neurodegenerative Disease Treatment—Focusing on Alzheimer’s Disease Personalised Diets
por: Palimariciuc, Matei, et al.
Publicado: (2023)

Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders
por: Nobili, Annalisa, et al.
Publicado: (2018)

The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
por: Caligiore, Daniele, et al.
Publicado: (2022)

The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar
por: Stakos, Dimitrios A., et al.
Publicado: (2020)

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy
por: Pagliarini, Vittoria, et al.
Publicado: (2015)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

Editorial for Special Issue: Microbial and Autoimmune Disease
por: D’Amelio, Raffaele
Publicado: (2021)

Tissue Renin–Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease
por: Skov, Jeppe, et al.
Publicado: (2014)

The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago
por: Snow, Alan David, et al.
Publicado: (2021)

Neuroprotective Role of Dietary Supplementation with Omega-3 Fatty Acids in the Presence of Basal Forebrain Cholinergic Neurons Degeneration in Aged Mice
por: Cutuli, Debora, et al.
Publicado: (2020)

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
por: Kametani, Fuyuki, et al.
Publicado: (2018)

Lipofuscin Hypothesis of Alzheimer's Disease
por: Giaccone, Giorgio, et al.
Publicado: (2011)

Infectious hypothesis of Alzheimer disease
por: Seaks, Charles E., et al.
Publicado: (2020)

Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer’s disease
por: Fanelli, Francesca, et al.
Publicado: (2013)

Converging links between adult-onset neurodegenerative Alzheimer’s disease and early life neurodegenerative neuronal ceroid lipofuscinosis?
por: Klein, Marcel, et al.
Publicado: (2022)

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
por: Amato, Antonella, et al.
Publicado: (2019)

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease
por: Thomas, J., et al.
Publicado: (2015)

Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease
por: Venkataraman, Lalitha, et al.
Publicado: (2020)

The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases
por: Li, Huifangjie, et al.
Publicado: (2019)

“Is dopamine involved in Alzheimer's disease?”
por: Martorana, Alessandro, et al.
Publicado: (2014)

Neuronal autophagy and neurodegenerative diseases
por: Son, Jin H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_csblrlkbrgrvot6pj81skhpheu